Frequentist evaluation of group sequential clinical trial designs.
about
On the Use of Local Assessments for Monitoring Centrally Reviewed Endpoints with Missing Data in Clinical TrialsA Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data.Sample size recalculation in sequential diagnostic trialsChallenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data.Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot.Methods for observational post-licensure medical product safety surveillance.Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part I: Frequentist Approaches.Sequential designs with small samples: Evaluation and recommendations for normal responses.Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study.An introduction to multiplicity issues in clinical trials: the what, why, when and how.Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.Adaptive methods: telling "the rest of the story".A practical guide to Bayesian group sequential designs.Sample size and screening size trade-off in the presence of subgroups with different expected treatment effects.Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples'.Assessing performance of sequential analysis methods for active drug safety surveillance using observational data.Alternative views on setting clinical trial futility criteria.Adaptive designs in clinical trials: why use them, and how to run and report them.Sequential Statistical Methods for Prospective Postmarketing Safety Surveillance
P2860
Q28649448-62E613FF-C7D8-4710-8B9C-58F57774B36EQ31135365-284A72D9-B0ED-47E9-8D42-E2D9537B1CF9Q33567119-F195A404-52D0-473F-AC87-47529A99D16CQ34133842-434DA3AD-B3F8-46AC-9036-255086024AA8Q34133849-EA6FAC95-5C8B-4651-8881-E8F00DB1B22FQ37964440-69239036-C9B3-42B7-93FC-3F3CF805E35DQ38853390-33AC509F-4B6C-42FA-9939-1D14AFF09863Q39656502-E4EAE228-B4F9-4F72-8B82-06E93A8EDD3AQ40261938-2069E050-40DA-42BD-AB07-CB120BD49355Q40406803-B011B2A8-151B-44F7-9194-8CB932F0668EQ41686667-5B00DD6A-6687-4078-8660-D9AED318C3DAQ42724434-221C981E-1527-41A2-9251-8CDA08C300F0Q44385353-CD330F6E-0849-4C31-9A96-B45B6DAB323CQ44711945-FABEC469-BB66-4ADA-A0E0-2A208A6259ADQ46058461-353BE327-F5A0-4D5C-96DE-AB236C36B2E2Q47180065-CA65A75D-7466-48A2-8EBD-CC64F2242DFBQ47342510-F109E309-679C-44E8-9975-60E01C7DB4BAQ47441653-76BCC327-AC14-4BE8-B601-0D397284D4C9Q47758774-6D7E65CE-FF56-4B26-A50F-660083D4ECA2Q52681001-F3F4FFFF-451E-4C98-AAC6-E5EEA1C819E1Q57590034-40FA81C7-9AAA-4BAF-AEE1-79FB86D39A99
P2860
Frequentist evaluation of group sequential clinical trial designs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Frequentist evaluation of group sequential clinical trial designs.
@en
Frequentist evaluation of group sequential clinical trial designs.
@nl
type
label
Frequentist evaluation of group sequential clinical trial designs.
@en
Frequentist evaluation of group sequential clinical trial designs.
@nl
prefLabel
Frequentist evaluation of group sequential clinical trial designs.
@en
Frequentist evaluation of group sequential clinical trial designs.
@nl
P2093
P356
P1476
Frequentist evaluation of group sequential clinical trial designs.
@en
P2093
Daniel L Gillen
John M Kittelson
Scott S Emerson
P304
P356
10.1002/SIM.2901
P407
P577
2007-12-01T00:00:00Z